The “dawn phenomenon” (DP) describes a pattern in which episodes of hyperglycemia are experienced by patients with diabetes or prediabetes during the early morning hours (usually between 3:00 and 8:00 AM). It typically occurs in the absence of prior nocturnal hypoglycemia. The term was first coined by Schmidt and colleagues in 1981 to refer to a rise in morning...
Category: <span>Clinical Practice</span>
Post
Awakening to the Dawn Phenomenon in Diabetes
The “dawn phenomenon” (DP) describes a pattern in which episodes of hyperglycemia are experienced by patients with diabetes or prediabetes during the early morning hours (usually between 3:00 and 8:00 AM). It typically occurs in the absence of prior nocturnal hypoglycemia. Schmidt and colleagues first coined the term in 1981 to refer to a rise in morning...
Post
Are GLP-1s the Newest Fertility Treatment?
First, there were “Ozempic babies.” Now, there is also Ozempic-before-baby. Unplanned pregnancies are still regularly being reported among people using glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, and now fertility specialists are increasingly incorporating the medicines into preconception care plans. The specialists say their colleagues in other areas of medicine may have an opportunity, too, to...
Post
Knowledge Gaps About Obesity Medicine Seen in Primary Care
San Antonio — Despite the prevalence of obesity in primary care, there appear to be major knowledge gaps among providers regarding obesity management, new research suggests. Anonymous surveys of 96 primary care providers at a Boston, Massachusetts, safety net hospital revealed that participants had limited understanding of criteria for prescribing antiobesity medications (AOM), and expressed...
Post
‘Ghost network’ of US healthcare providers amounts to fraud
New lawsuit finds ‘staggering’ cases of people struggling to find mental health care coinciding with mental health crisis Jessica Glenza Mon 4 Nov 2024 07.00 EST Share Many people have likely had the experience where they are in need of a psychologist, therapist or addiction specialist, and struggle to find one covered by their insurance....
Post
How can physical therapy help neurological disorders?
Physical therapy for neurological disorders can help manage several conditions. Healthcare professionals may use different methods to help manage symptoms and improve quality of life. Neurological conditions affect the brain, nerves, and spinal cord. People with these conditions may have changes to their senses, movement, and how they communicate. They may also experience changes in...
Post
Starting physical activity after dementia diagnosis may reduce death risk by 20%
Scientists have found cognitive benefits from regular exercise for people at risk for dementia. sofie delauw/Stocksy Physical activity can offer multiple benefits, from weight management to decreasing the risk of heart disease. It may also help lower the risk of developing dementia. Another area of interest is the effects of physical activity after dementia has already been diagnosed....
Post
Expert Guidance Issued for Real-World Use of Donanemab
An expert workgroup has developed the first appropriate use recommendations (AURs) for real-world use of the antiamyloid donanemab (Kisunla). “The role of appropriate use recommendations are to bridge the gap between clinical trials and clinical practice,” said author Gil Rabinovici, MD, with the Department of Neurology, University of California, San Francisco. “We know that patients...
Post
Hormone Therapy and Dementia: What Do We Know?
Estrogen exerts neuroprotective effects on the brain, and the reduction in endogenous estrogen after menopause increases women’s risk for Alzheimer’s disease (AD), cerebrovascular disease, or both. However, there is debate whether estrogen replacement — with or without progestin — is neuroprotective or whether it may in fact increase the risk for AD and other dementias. “Research on hormone...
Post
FDA Approves Novel Treatment for UTIs
New oral antibiotic gets a nod for uncomplicated urinary tract infections by Judy George, Deputy Managing Editor, MedPage TodayOctober 25, 2024 The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) caused by certain bacteria in women with limited or no alternative oral antibacterial treatment options, the agency saidopens in a new tab...